Live Breaking News & Updates on Chronic sinusitis

Prevent Sinus Problems in Winter | Tips from ENT Specialist |

Learn how to prevent sinus problems in winter. This article provides vital tips from an ENT specialist to alleviate sinusitis symptoms. Discover effective methods to soothe and moisturize nasal passages, ease congestion, and encourage sinus drainage.

Mumbai , Maharashtra , India , Karol-bagh , Delhi , Sanjiv-dang , Rajendra-waghela , Apollo-spectra-delhi , Medicover-hospitals , Blood-pressure , Winter

Sinus Problems Can Be A Silent Threat: 7 Tips To Save Yourself From A Dripping Nose

Untreated sinus problems can lead to severe and potentially life-threatening complications. Be aware of the facts to stay safe. TheHealthSite.com

Silent-threat , Shouldnt-ignore-nose-dripping , Prevent-sinus , Sinusitis , Chronic-sinusitis , Protecting-sinus-health , Runny-nose ,

Endoscopic Sinus Surgery Has No Impact on Comorbid Asthma

Patients with both conditions showed no difference in asthma symptom severity or medication use before and after surgery.

United-states , Jacksonville , Florida , San-francisco , California , American , Megan-durr , Bohorquez-caballero , Bohorquez-cabellero , Anyull-dayanna-bohorquez-caballero , Angela-donaldson , Global-initiative-for-asthma

Chronic sinusitis not majorly associated with cancer

Chronic sinusitis plays only a minor role in the development of head and neck cancer (HNC), reveals a recent research.

Danielc-beachler , National-cancer-institute , End-results , Study , Ancer , Ink , Chronic-sinusitis , Nc , Head-and-neck-cancer ,

OptiNose, Inc. (NASDAQ:OPTN) Q2 2023 Earnings Call Transcript

OptiNose, Inc. (NASDAQ:OPTN) Q2 2023 Earnings Call Transcript August 10, 2023 OptiNose, Inc. beats earnings expectations. Reported EPS is $0.02, expectations were $-0.11. Operator: Hello. Good day everyone and thank you for standing by. Welcome to the OptiNose Second Quarter 2023 Earnings Call. At this time, all participants are in a listen only mode. After […]

Lighthunter-shutterstock , Jonathan-neely , Ramy-mahmoud , Optinose , Hance , Orward-looking-statements , Optinose , Nc- , Chronic-sinusitis , Ramy-mahmoud ,

Sinusitis - Types, Causes, Symptoms, Diagnosis, Complications and Treatment

Infections like sinus headache and stuffy nose can be due to acute or chronic sinusitis, affecting the maxillary sinus and other sinuses.

United-states , Chicago , Illinois , Himabindu-venkatakrishnan , Health-tips-for-sinusitis-face-masks , Chronic-sinusitis , Nasal-septum , Sinusitis-frequent , Sinusitis-breathe , Sinusitis-face , Respiratory-complications , Common-variable

Sinus Therapeutic Drugs Market is expected to reach US$ 6.35 billion by 2032

According to Future Market Insights (FMI), an ESOMAR-certified consultancy, the global Sinus Therapeutic Drugs Market size will reach US$ 6.35 billion by 2032, rising at a stable CAGR of 4% through 2032.One of the most important aspects driving the Sinus Therapeutic Drugs market is the introduction of biologics.Omal...

United-states , Delaware , New-york , America , Regeneron-pharmaceuticals-inc , Glaxosmithkline , Greater-new-york-chamber , Drug-administration , Market-insights-inc , Route-of-administration , Linkedin

Global Intranasal Drug Delivery Strategic Markets Report 2023-2030: Nasal Drug Delivery Offers New Opportunities for Drug Developers as Patent Cliffs Usher in Dusk of Blockbuster Era

/PRNewswire/ -- The "Intranasal Drug Delivery: Global Strategic Business Report" report has been added to ResearchAndMarkets.com s offering. Global Intranasal...

Germany , Australia , Japan , India , China , Canada , Russia , Dublin , Ireland , South-korea , Ukraine , Laura-wood

Optinose Announces Reporting Date for Fourth Quarter 2022

Conference Call and Webcast to be held March 7, 2023 at 8:00 a.m. Eastern Time...

Jonathan-neely , Linkedin , Twitter , Members-of-the-company , Company-to-host-conference-call , Ghost-conference , Nasdaq-optn , Optinose , Nc- , Bmptn , Hance , Chronic-rhinosinusitis

Optinose Announces CEO Transition and Business Update

Optinose Announces CEO Transition and Business Update - read this article along with other careers information, tips and advice on BioSpace

Peter-miller , Jonathan-neely , Josephc-scodari , Ramy-mahmoud , Walter-reed-army-institute-of-research , Linkedin , Twitter , Nasdaq , Exchange-commission , Harvard-school-of-public-health , Optinose-inc , Department-of-epidemiology